Researchers at Johns Hopkins University have identified a process in the eye that may explain why biologic drugs for treating ...

New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...

A new study explains not only why some patients with wet age-related macular degeneration (or 'wet' AMD) fail to have vision improvement with treatment, but also how an experimental drug could be used ...